Home / Inspections / 1206682

FDA Inspection 1206682 — Palo Alto Medical Foundation Reproductive Endocrinology and Infertility

Palo Alto Medical Foundation Reproductive Endocrinology and Infertility — FEI 3003969236

The FDA completed an inspection of Palo Alto Medical Foundation Reproductive Endocrinology and Infertility on May 10, 2023 in San Jose, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 10, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Jose, CA (United States)

Facility

Other inspections at this facility

  • 1021941 (NAI Thu Aug 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 930239 (NAI Mon Jun 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 785515 (NAI Thu Jun 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 604689 (NAI Thu Aug 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources